http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#Head
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#assertion
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#provenance
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#pubinfo
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#assertion
http://purl.obolibrary.org/obo/DOID_1826
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_1826
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00313
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association
http://www.w3.org/2000/01/rdf-schema#label
1 1 mania divalproex sodium delayed release tablets are a valproate and are indicated for the treatment of the manic episodes associated with bipolar disorder a manic episode is a distinct period of abnormally and persistently elevated expansive or irritable mood typical symptoms of mania include pressure of speech motor hyperactivity reduced need for sleep flight of ideas grandiosity poor judgment aggressiveness and possible hostility the efficacy of divalproex sodium delayed release tablets were established in 3 week trials with patients meeting dsm iii r criteria for bipolar disorder who were hospitalized for acute mania see clinical studies 14 1 the safety and effectiveness of divalproex sodium delayed release tablets for long term use in mania i e more than 3 weeks has not been demonstrated in controlled clinical trials therefore healthcare providers who elect to use divalproex sodium delayed release tablets for extended periods should continually reevaluate the long term usefulness of the drug for the individual patient 1 2 epilepsy divalproex sodium delayed release tablets are indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures divalproex sodium delayed release tablets are also indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures and adjunctively in patients with multiple seizure types that include absence seizures simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs complex absence is the term used when other signs are also present 1 3 migraine divalproex sodium delayed release tablets are indicated for prophylaxis of migraine headaches there is no evidence that divalproex sodium delayed release tablets are useful in the acute treatment of migraine headaches 1 4 important limitations because of the risk to the fetus of decreased iq neural tube defects and other major congenital malformations which may occur very early in pregnancy valproate should not be administered to a woman of childbearing potential unless the drug is essential to the management of her medical condition see warnings and precautions 5 2 5 3 5 4 8 1 17 3 divalproex sodium delayed release tablets are contraindicated for prophylaxis of migraine headaches in women who are pregnant
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00313
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#provenance
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#pubinfo
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#sig
http://purl.org/nanopub/x/hasSignature
RdoQbmO0MiZpn7SzmxfqboxMQybMA7YbsmGYDlWy3aqmlNAAsnCBzd5/m7SW8uOa353RgVHaH4OSCjDARZgCBQFNJfGRhqGGvT0X5SaOm7Tk7RGwMNitOzExNkHT6Eh8c0fN0M9WJza7sj/V4XEeDMWjKlHTSNpZz4XdHUQCpPU=
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
http://purl.org/dc/terms/created
2021-06-30T08:53:54.519+02:00
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs